|
|
Weekly News Digest
 |
November 14, 2011 — In addition to this week's NewsBreaks article and the monthly NewsLink Spotlight, Information Today, Inc. (ITI) offers Weekly News Digests that feature recent product news and company announcements. Watch for additional coverage to appear in the next print issue of Information Today.
CLICK HERE to view more Weekly News Digest items.
|
Springer to Acquire Pharma Marketing and Publishing Services From Wolters Kluwer
Springer Science+Business Media reached an agreement with Wolters Kluwer to acquire the Pharma Marketing and Publishing Services division (MPS) for its Springer Healthcare unit. MPS is one of the five largest global providers of strategic marketing, publishing and business intelligence products and services to the pharmaceutical industry, as well as to medical libraries and academic and research institutions. The announcement follows an earlier announcement by Wolters Kluwer in July that it planned to divest its pharma-related assets. The transaction is subject to customary closing conditions, including regulatory approvals.The agreement encompasses the Marketing & Publishing Services business unit, part of the Wolters Kluwer Health & Pharma Solutions division. The sale represents about 35% of the company’s pharma-related assets in terms of revenue, with Adis and inScience Communications as the leading brands, and encompasses about 450 employees globally. MPS’s Adis unit publishes a portfolio of 24 highly regarded scientific journals and newsletters specializing in pharmacology and pharmacotherapy. Further MPS services include drug development and drug safety databases, commercial market analysis, strategic medical and marketing communications programs, prescriber and patient education materials, and pharmaceutical sales force training, among others. The company has approximately 450 employees, and its main offices are in Auckland (New Zealand), Chester (U.K.), Yardley, Pa. (U.S.), and Milan (Italy). Derk Haank, CEO of Springer Science+Business Media, said: “This acquisition will significantly strengthen our position in international corporate and healthcare markets, and will also allow us to expand Springer’s STM operations, not only in the Americas and Asia-Pacific regions, but also in parts of Europe where we do not yet have offices. MPS’s high-quality content and services for corporate customers and academics form a perfect complement to our existing portfolio.” Nancy McKinstry, CEO and chairman of the Executive Board of Wolters Kluwer, said, “The sale of our pharma-related business is part of our strategy to focus on our core health markets and accelerate growth by providing innovative solutions to clinicians globally.” Sources: Springer Science+Business Media and Wolters Kluwer
Send correspondence concerning the Weekly News Digest to NewsBreaks Editor
Brandi Scardilli
|
